This inventor holds 1 USPTO granted patent. Top assignee: Chong Kun Dang Corporation. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Innovations of Hyeog Jin Son in Immunosuppressive Agents
Introduction
Hyeog Jin Son is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of immunosuppressive agents through his innovative research and development. His work focuses on the discovery and application of novel compounds that can aid in medical treatments.
Latest Patents
Hyeog Jin Son holds a patent for a process involving a microorganism, specifically a Streptomyces sp., which produces tautomycetin. This compound possesses immunosuppressive and antibacterial activities. The patent details a method for preparing tautomycetin from the microorganism, as well as its application in immunosuppressive pharmaceutical compositions. The invention is particularly relevant for its ability to suppress interleukin-2 production and expression of CD69 and interleukin-2 receptor (IL-2R) on cell surfaces, which is crucial in preventing graft rejection during organ transplantation.
Career Highlights
Hyeog Jin Son is associated with Chong Kun Dang Corporation, where he continues to advance his research in the field of pharmaceuticals. His innovative approach has led to the isolation of a soil microorganism that produces tautomycetin, marking a significant milestone in antibiotic and immunosuppressive research.
Collaborations
Hyeog Jin Son has collaborated with notable colleagues, including Hyoung Sik Chun and Jong Gwan Kim, to further enhance the research and development of immunosuppressive agents.
Conclusion
Hyeog Jin Son's contributions to the field of immunosuppressive agents through his patent on tautomycetin highlight the importance of innovation in medical research. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in organ transplantation.